Abstract
Cell transplantation is a promising strategy for the treatment of neurodegenerative and muscle degenerative diseases. Many kinds of cells, including embryonic stem cells and tissue stem cells, have been considered as candidates for transplantation therapy. Bone marrow stromal cells (MSCs) have great potential as therapeutic agents since they are easy to isolate and can be expanded from patients without serious ethical or technical problems. We discovered a new method for the highly efficient and specific induction of functional Schwann cells, neurons and skeletal muscle lineage cells from both rat and human MSCs. These induced cells were transplanted into animal models of neurotraumatic injuries, Parkinsons disease, stroke and muscle dystrophies, resulting in the successful integration of transplanted cells and an improvement in behavior of the transplanted animals. Here we focus on the respective potentials of MSCderived cells and discuss the possibility of clinical application in degenerative diseases.
Keywords: mesenchymal cell, transdifferentiation, regenerative medicine, cell therapy, transplantation, schwann cells, neuronal differentiation, myogenic differentiation
Current Neuropharmacology
Title: Potential of Bone Marrow Stromal Cells in Applications for Neuro-Degenerative, Neuro-Traumatic and Muscle Degenerative Diseases
Volume: 3 Issue: 4
Author(s): M. Dezawa, H. Ishikawa, M. Hoshino, Y. Itokazu and Yo-ichi Nabeshima
Affiliation:
Keywords: mesenchymal cell, transdifferentiation, regenerative medicine, cell therapy, transplantation, schwann cells, neuronal differentiation, myogenic differentiation
Abstract: Cell transplantation is a promising strategy for the treatment of neurodegenerative and muscle degenerative diseases. Many kinds of cells, including embryonic stem cells and tissue stem cells, have been considered as candidates for transplantation therapy. Bone marrow stromal cells (MSCs) have great potential as therapeutic agents since they are easy to isolate and can be expanded from patients without serious ethical or technical problems. We discovered a new method for the highly efficient and specific induction of functional Schwann cells, neurons and skeletal muscle lineage cells from both rat and human MSCs. These induced cells were transplanted into animal models of neurotraumatic injuries, Parkinsons disease, stroke and muscle dystrophies, resulting in the successful integration of transplanted cells and an improvement in behavior of the transplanted animals. Here we focus on the respective potentials of MSCderived cells and discuss the possibility of clinical application in degenerative diseases.
Export Options
About this article
Cite this article as:
Dezawa M., Ishikawa H., Hoshino M., Itokazu Y. and Nabeshima Yo-ichi, Potential of Bone Marrow Stromal Cells in Applications for Neuro-Degenerative, Neuro-Traumatic and Muscle Degenerative Diseases, Current Neuropharmacology 2005; 3 (4) . https://dx.doi.org/10.2174/157015905774322507
DOI https://dx.doi.org/10.2174/157015905774322507 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Nitric Oxide (NO) Signaling as a Potential Therapeutic Modality Against Psychostimulants
Current Pharmaceutical Design Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
Current Pharmaceutical Design Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Pharmacological Approaches to Induce Neuroregeneration in Spinal Cord Injury: An Overview
Current Drug Discovery Technologies IL-1 as a target in inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Subject Index to Volume 2
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Survival Signaling Pathways Activated by NMDA Receptors
Current Topics in Medicinal Chemistry The Fall in Older Adults: Physical and Cognitive Problems
Current Aging Science Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System
Current Neuropharmacology Role of Matrix Metalloproteinases in Animal Models of Ischemic Stroke
Current Vascular Pharmacology The Metabolism of Anthocyanins
Current Drug Metabolism Nitrogen, Oxygen or Sulfur Containing Heterocyclic Compounds as Analgesic Drugs Used as Modulators of the Nitroxidative Stress
Mini-Reviews in Medicinal Chemistry Microbial Exo-Polysaccharides for Biomedical Applications
Mini-Reviews in Medicinal Chemistry Functional Roles of Synaptic and Extrasynaptic NMDA Receptors in Physiological and Pathological Neuronal Activities
Current Drug Targets Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Current Pharmaceutical Design GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors
Current Medicinal Chemistry Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases
CNS & Neurological Disorders - Drug Targets Brain Slices as Models for Neurodegenerative Disease and Screening Platforms to Identify Novel Therapeutics
Current Neuropharmacology Leptin as a Novel Therapeutic Target for Immune Intervention
Current Drug Targets - Inflammation & Allergy Endocannabinoids and their Involvement in the Neurovascular System
Current Neurovascular Research